Following the spectacular crash and burn of the Symplicity HTN-3 trial at the American College of Cardiology two weeks ago, the future of renal denervation (RDN)-- the once highly promising catheter ...
REDWOOD CITY, Calif. — OPENLANE chief executive officer Daniel Farrar looked to quell any apprehension from recovery agencies about the online auction company's recent acquisition of Recovery Database ...
Paradise Ultrasound Renal Denervation System About the Paradise uRDN System The Paradise uRDN system is a novel ...
Medtronic plc MDT recently announced long-term data from the first 80 patients in the SPYRAL HTN-ON MED trial. The SPYRAL HTN-ON MED is a global, randomized, sham-controlled study investigating the ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the U.S. Food and Drug ...
Interv Cardiol. 2014;6(1):57-69. Appropriate patient selection is critical, and should be made by a hypertension expert in a specialized center. Optimal medical therapy is an important prerequisite, ...
With the Consumer Financial Protection Bureau intensifying its regulatory aim at the auto finance industry, Recovery Database Network (RDN) is launching a new technology product called VendorVision, ...
DeepQure Inc., a pioneering medical device startup, is revolutionizing the treatment of resistant hypertension with its innovative extravascular (laparoscopic approach) renal denervation (RDN) device, ...
TOKYO--(BUSINESS WIRE)--Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) and Recor Medical, Inc. (“Recor”, subsidiary of Otsuka Medical Devices) announced the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results